Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
2.920
+0.150 (5.42%)
Nov 26, 2025, 4:00 PM EST - Market closed
Health Catalyst Revenue
Health Catalyst had revenue of $76.32M in the quarter ending September 30, 2025, a decrease of -0.04%. This brings the company's revenue in the last twelve months to $316.06M, up 4.64% year-over-year. In the year 2024, Health Catalyst had annual revenue of $306.58M with 3.60% growth.
Revenue (ttm)
$316.06M
Revenue Growth
+4.64%
P/S Ratio
0.63
Revenue / Employee
$210,709
Employees
1,500
Market Cap
206.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 306.58M | 10.65M | 3.60% |
| Dec 31, 2023 | 295.94M | 19.70M | 7.13% |
| Dec 31, 2022 | 276.24M | 34.31M | 14.18% |
| Dec 31, 2021 | 241.93M | 53.08M | 28.11% |
| Dec 31, 2020 | 188.85M | 33.90M | 21.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
HCAT News
- 12 days ago - Health Catalyst to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - UnityPoint Health to Unlock Next Phase of Analytics Innovation by Activating Health Catalyst Ignite™ - PRNewsWire
- 16 days ago - Health Catalyst Achieves HITRUST r2 Certification, Demonstrating the Highest Level of Information Protection Assurance - PRNewsWire
- 16 days ago - Health Catalyst Reports Third Quarter 2025 Results - GlobeNewsWire
- 4 weeks ago - Impax Small Cap Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 5 weeks ago - Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025 - GlobeNewsWire
- 2 months ago - Health Catalyst Appoints Ben Albert to the Role of President and COO - PRNewsWire